Cost-Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: An Economic Evaluation Based on Network Meta-Analysis

To assess the cost-effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer from the US healthcare sector perspective with a lifetime horizon.

Source: Value in Health - December 1, 2021 Category: International Medicine & Public Health Authors: Lin Wang, Hwanhee Hong, G. Caleb Alexander, Otis W. Brawley, Channing J. Paller, Jeromie Ballreich Tags: Economic Evaluation Source Type: research